BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 7863150)

  • 1. [Paraneoplastic cerebellar degeneration].
    Chabriat H; Chen QM; Poisson M; Delattre JY
    Rev Neurol (Paris); 1994; 150(2):105-14. PubMed ID: 7863150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathological advances on central nervous system paraneoplastic syndromes.
    Graus F; René R
    Rev Neurol (Paris); 1992; 148(6-7):496-501. PubMed ID: 1448670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic cerebellar degeneration: clinical-immunological correlations.
    Anderson NE; Rosenblum MK; Posner JB
    Ann Neurol; 1988 Oct; 24(4):559-67. PubMed ID: 3239956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
    Tremouilhac C; Hamy A; De Ferron E; Paineau J; Visset J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):253-6. PubMed ID: 8767221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pure cerebellar syndrome associated with anti-Hu antibodies].
    Pradat PF; Uchuya M; Fontaine B; Lubetzki C
    Rev Neurol (Paris); 1995 May; 151(5):341-3. PubMed ID: 7481393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoimmunity and paraneoplastic neurologic syndromes].
    Delattre JY; Davila L; Vega F; Poisson M
    Rev Neurol (Paris); 1991; 147(8-9):549-56. PubMed ID: 1962063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K; Tanaka M; Onodera O; Tsuji S
    Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paraneoplastic cerebellar degeneration].
    Nakano R; Sato S
    Nihon Rinsho; 1994 Nov; 52(11):3000-5. PubMed ID: 7996701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurologic paraneoplastic syndromes and anti-neuronal antibodies].
    Mygland A
    Tidsskr Nor Laegeforen; 1996 Jan; 116(3):361-5. PubMed ID: 8638263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations].
    Dalmau J; Porta-Etessam J
    Rev Neurol; 2000 Dec 16-31; 31(12):1213-9. PubMed ID: 11205562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.
    Furneaux HM; Rosenblum MK; Dalmau J; Wong E; Woodruff P; Graus F; Posner JB
    N Engl J Med; 1990 Jun; 322(26):1844-51. PubMed ID: 2348838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoimmunity and cancer: paraneoplastic neurological syndromes associated with small cell cancer].
    Zenone T
    Bull Cancer; 1992; 79(9):837-53. PubMed ID: 1336687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic syndromes associated with anti-Hu antibodies.
    Senties-Madrid H; Vega-Boada F
    Isr Med Assoc J; 2001 Feb; 3(2):94-103. PubMed ID: 11344832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M; Tanaka K; Idezuka J; Tsuji S
    Exp Neurol; 1998 Apr; 150(2):337-8. PubMed ID: 9527904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma].
    Huober J; Niedermaier N; Drlicek M; Kaufmann M; Hacke W; Bastert G
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):214-6. PubMed ID: 8682288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer.
    Rojas-Marcos I; Rousseau A; Keime-Guibert F; Reñé R; Cartalat-Carel S; Delattre JY; Graus F
    Medicine (Baltimore); 2003 May; 82(3):216-23. PubMed ID: 12792307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin. A case report.
    David YB; Warner E; Levitan M; Sutton DM; Malkin MG; Dalmau JO
    Cancer; 1996 Nov; 78(10):2153-6. PubMed ID: 8918408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies.
    Storstein A; Krossnes BK; Vedeler CA
    Acta Neurol Scand; 2009 Jul; 120(1):64-7. PubMed ID: 19486326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The detection of anti-Purkinje cell antibody (anti-Yo antibody) by ELISA using recombinant Yo fusion protein].
    Tanaka K; Tanaka M; Onodera O; Igarashi S; Tsuji S
    No To Shinkei; 1994 Jan; 46(1):47-51. PubMed ID: 8136199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
    Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.